• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体氧化磷酸化系统的改变:人类心力衰竭中复合物V与心脏功能障碍的关系。

Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure.

作者信息

Giménez-Escamilla Isaac, Benedicto Carlota, Pérez-Carrillo Lorena, Delgado-Arija Marta, González-Torrent Irene, Vilchez Roger, Martínez-Dolz Luis, Portolés Manuel, Tarazón Estefanía, Roselló-Lletí Esther

机构信息

Clinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Avd. Fernando Abril Martorell 106, 46026 Valencia, Spain.

Center for Biomedical Research Network on Cardiovascular Diseases (CIBERCV), Avd. Monforte de Lemos 3-5, 28029 Madrid, Spain.

出版信息

Antioxidants (Basel). 2024 Feb 26;13(3):285. doi: 10.3390/antiox13030285.

DOI:10.3390/antiox13030285
PMID:38539818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10967419/
Abstract

Heart failure (HF) is a disease related to bioenergetic mitochondrial abnormalities. However, the whole status of molecules involved in the oxidative phosphorylation system (OXPHOS) is unknown. Therefore, we analyzed the OXPHOS transcriptome of human cardiac tissue by RNA-seq analyses (mRNA = 36; ncRNA = 30) in HF patients (ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM)) and control subjects. We detected 28 altered genes in these patients, highlighting greater deregulation in ICM. Specifically, we found a general overexpression of complex V (ATP synthase) elements, among them, (ICM, FC = 2.04; < 0.01), (ICM, FC = 1.33, < 0.05), and (ICM, FC = 1.81; < 0.001), which presented a significant correlation with established echocardiographic parameters of cardiac remodeling and ventricular function as follows: left ventricular end-systolic ( < 0.01) and end-diastolic ( < 0.01) diameters, and ejection fraction ( < 0.05). We also detected an increase in ATP5IF1 protein levels (ICM, FC = 1.75; < 0.01) and alterations in the microRNA expression levels of miR-208b-3p (ICM, FC = -1.44, < 0.001), miR-483-3p (ICM, FC = 1.37, < 0.01), regulators of . Therefore, we observed the deregulation of the OXPHOS transcriptome in ICM patients, highlighting the overexpression of complex V and its relationship with cardiac remodeling and function.

摘要

心力衰竭(HF)是一种与生物能量线粒体异常相关的疾病。然而,氧化磷酸化系统(OXPHOS)中涉及的分子的整体状态尚不清楚。因此,我们通过RNA测序分析(mRNA = 36;非编码RNA = 30)对心力衰竭患者(缺血性心肌病(ICM)和扩张型心肌病(DCM))及对照受试者的人心脏组织的OXPHOS转录组进行了分析。我们在这些患者中检测到28个改变的基因,突出显示ICM中存在更大程度的失调。具体而言,我们发现复合物V(ATP合酶)元件普遍过表达,其中,(ICM,FC = 2.04;<0.01),(ICM,FC = 1.33,<0.05),以及(ICM,FC = 1.81;<0.001),它们与已确立的心脏重塑和心室功能的超声心动图参数呈显著相关性,如下:左心室收缩末期(<0.01)和舒张末期(<0.01)直径,以及射血分数(<0.05)。我们还检测到ATP5IF1蛋白水平升高(ICM,FC = 1.75;<0.01)以及miR-208b-3p(ICM,FC = -1.44,<0.001)、miR-483-3p(ICM,FC = 1.37,<0.01)的微小RNA表达水平改变,它们是……的调节因子。因此,我们观察到ICM患者中OXPHOS转录组的失调,突出显示复合物V的过表达及其与心脏重塑和功能的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/8c83816c0d9a/antioxidants-13-00285-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/6826e97579a4/antioxidants-13-00285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/45889afae5aa/antioxidants-13-00285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/48d6a14c2b51/antioxidants-13-00285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/8c83816c0d9a/antioxidants-13-00285-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/6826e97579a4/antioxidants-13-00285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/45889afae5aa/antioxidants-13-00285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/48d6a14c2b51/antioxidants-13-00285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56fe/10967419/8c83816c0d9a/antioxidants-13-00285-g004a.jpg

相似文献

1
Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure.线粒体氧化磷酸化系统的改变:人类心力衰竭中复合物V与心脏功能障碍的关系。
Antioxidants (Basel). 2024 Feb 26;13(3):285. doi: 10.3390/antiox13030285.
2
Transcriptomic Alterations in Spliceosome Components in Advanced Heart Failure: Status of Cardiac-Specific Alternative Splicing Factors.剪接体成分在晚期心力衰竭中的转录组改变:心脏特异性可变剪接因子的状态。
Int J Mol Sci. 2024 Sep 4;25(17):9590. doi: 10.3390/ijms25179590.
3
Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.人类心力衰竭转录组分析揭示扩张型心肌病中细胞黏附失调和缺血性心力衰竭中激活的免疫途径。
BMC Genomics. 2018 Nov 12;19(1):812. doi: 10.1186/s12864-018-5213-9.
4
Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.缺血性心肌病和特发性扩张型心肌病中心脏再同步治疗的不同结果。
Heart Rhythm. 2011 Mar;8(3):377-82. doi: 10.1016/j.hrthm.2010.11.013. Epub 2010 Nov 9.
5
Heart failure entails significant changes in human nucleocytoplasmic transport gene expression.心力衰竭会导致人类核质转运基因表达发生显著变化。
Int J Cardiol. 2013 Oct 3;168(3):2837-43. doi: 10.1016/j.ijcard.2013.03.192. Epub 2013 May 4.
6
Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in ischaemic and dilated cardiomyopathy induced heart failure.mRNA 和 microRNA 表达谱的综合分析揭示了缺血性和扩张型心肌病诱导心力衰竭的差异转录组特征。
Epigenetics. 2021 Aug;16(8):917-932. doi: 10.1080/15592294.2020.1827721. Epub 2020 Oct 4.
7
Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.核质转运相关基因的功能网络可区分缺血性和扩张型心肌病。一个新的治疗机会。
PLoS One. 2014 Aug 19;9(8):e104709. doi: 10.1371/journal.pone.0104709. eCollection 2014.
8
Altered MicroRNA Maturation in Ischemic Hearts: Implication of Hypoxia on XPO5 and DICER1 Dysregulation and RedoximiR State.缺血性心脏中微小RNA成熟的改变:缺氧对XPO5和DICER1失调及氧化还原微小RNA状态的影响
Antioxidants (Basel). 2023 Jun 24;12(7):1337. doi: 10.3390/antiox12071337.
9
Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.外科心室重建和二尖瓣复合体重建对非缺血性和缺血性扩张型心肌病心脏氧化代谢和效率的影响。
JACC Cardiovasc Imaging. 2011 Jul;4(7):762-70. doi: 10.1016/j.jcmg.2011.04.010.
10
Predictive values of left ventricular mechanical dyssynchrony for CRT response in heart failure patients with different pathophysiology.左心室机械不同步对不同病理生理心力衰竭患者 CRT 反应的预测价值。
J Nucl Cardiol. 2022 Oct;29(5):2637-2648. doi: 10.1007/s12350-021-02796-3. Epub 2021 Sep 17.

引用本文的文献

1
Metformin Activation of Sirtuin 3 Signaling Regulates Mitochondrial Function Improves Diabetes-Associated Cognitive Impairment.二甲双胍激活沉默调节蛋白3信号通路调节线粒体功能改善糖尿病相关认知障碍。
Diabetes Metab Syndr Obes. 2025 Jul 12;18:2317-2330. doi: 10.2147/DMSO.S516173. eCollection 2025.
2
A New Perspective on the Role of Alterations in Mitochondrial Proteins Involved in ATP Synthesis and Mobilization in Cardiomyopathies.关于参与心肌病中ATP合成与转运的线粒体蛋白改变作用的新视角
Int J Mol Sci. 2025 Mar 19;26(6):2768. doi: 10.3390/ijms26062768.
3
Lab-grown, 3D extracellular matrix particles improve cardiac function and morphology in myocardial ischemia.

本文引用的文献

1
The ratio of cytochrome c oxidase subunit 4 isoform 4I1 and 4I2 mRNA is changed in permanent atrial fibrillation.细胞色素 c 氧化酶亚基 4 同工型 4I1 和 4I2mRNA 的比例在永久性心房颤动中发生改变。
ESC Heart Fail. 2024 Jun;11(3):1525-1539. doi: 10.1002/ehf2.14607. Epub 2023 Dec 27.
2
Pathogenic BCS1L Mutation Resulting in Hypertrophic Cardiomyopathy: A Unique Presentation of Nuclear Mitochondrial Disease.致病性 BCS1L 突变导致肥厚型心肌病:核线粒体疾病的独特表现。
Tex Heart Inst J. 2023 Mar 1;50(2). doi: 10.14503/THIJ-21-7730.
3
Mitochondria-Related Transcriptome Characterization Associated with the Immune Microenvironment, Therapeutic Response and Survival Prediction in Pancreatic Cancer.
实验室培育的三维细胞外基质颗粒可改善心肌缺血时的心脏功能和形态。
Am J Physiol Heart Circ Physiol. 2025 Feb 1;328(2):H221-H234. doi: 10.1152/ajpheart.00581.2024. Epub 2024 Dec 20.
4
Pathological Alterations in Heart Mitochondria in a Rat Model of Isoprenaline-Induced Myocardial Injury and Their Correction with Water-Soluble Taxifolin.应激性心肌损伤大鼠模型中心脏线粒体的病理改变及其水溶性金雀异黄素的纠正作用。
Int J Mol Sci. 2024 Oct 29;25(21):11596. doi: 10.3390/ijms252111596.
5
Transcriptomic Alterations in Spliceosome Components in Advanced Heart Failure: Status of Cardiac-Specific Alternative Splicing Factors.剪接体成分在晚期心力衰竭中的转录组改变:心脏特异性可变剪接因子的状态。
Int J Mol Sci. 2024 Sep 4;25(17):9590. doi: 10.3390/ijms25179590.
线粒体相关转录组特征与胰腺癌免疫微环境、治疗反应和生存预测相关。
Int J Mol Sci. 2023 Feb 7;24(4):3270. doi: 10.3390/ijms24043270.
4
Mitochondrial Complex I, a Possible Sensible Site of cAMP Pathway in Aging.线粒体复合体I,衰老过程中cAMP信号通路的一个可能敏感位点。
Antioxidants (Basel). 2023 Jan 18;12(2):221. doi: 10.3390/antiox12020221.
5
Common methods in mitochondrial research (Review).线粒体研究中的常见方法(综述)。
Int J Mol Med. 2022 Oct;50(4). doi: 10.3892/ijmm.2022.5182. Epub 2022 Aug 25.
6
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
7
Mitochondria as Therapeutic Targets in Heart Failure.线粒体作为心力衰竭的治疗靶点。
Curr Heart Fail Rep. 2022 Apr;19(2):27-37. doi: 10.1007/s11897-022-00539-0. Epub 2022 Feb 11.
8
Mitochondrial dysfunction and mitochondrial therapies in heart failure.心力衰竭中的线粒体功能障碍和线粒体治疗。
Pharmacol Res. 2022 Jan;175:106038. doi: 10.1016/j.phrs.2021.106038. Epub 2021 Dec 17.
9
Epidemiology of Heart Failure: A Contemporary Perspective.心力衰竭的流行病学:当代观点。
Circ Res. 2021 May 14;128(10):1421-1434. doi: 10.1161/CIRCRESAHA.121.318172. Epub 2021 May 13.
10
TRESK Regulates Gm11874 to Induce Apoptosis of Spinal Cord Neurons via ATP5i Mediated Oxidative Stress and DNA Damage.TRESK通过ATP5i介导的氧化应激和DNA损伤调节Gm11874以诱导脊髓神经元凋亡。
Neurochem Res. 2021 Aug;46(8):1970-1980. doi: 10.1007/s11064-021-03318-w. Epub 2021 May 10.